The injectable form was approved by the US FDA for chemotherapy induced nausea in December 1993. It has since been used for radiation therapy induced nausea. Kytril is a selective blocking agent of the seretonin 5-HT 3 receptor. This triggers the vomiting reflex. If this mechanism can be blocked with drugs such as Kytril, vomiting can be reduced or eliminated.
Insurance often covers the cost.
The injectable form is often given in conjunction with chemotherapy. The oral form is suited for doctor prescribed patient use after chemotherapy or radiotherapy. The medicine should not be given to others or us it for conditions not prescribed by your medical team. Seek medical attention on overdose. Kytril may cause headache, constipation, weakness, drowsiness, or diarrhea.